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ABSTRACT  Bovine  brain  and  pituitary  fibroblast  growth  factors  (FGF) have  been  compared 
with regard  to their chemical  and biological  properties.  Pituitary and one preparation of brain 
FGF  (Prep  A)  contain  a  basic  mitogenic  activity,  which  migrates  to  the  same  position  on 
electrophoresis  in acid  pH  gels  as detected  by  incorporation  of  [methyl-3H]-thymidine  into 
BALB/c 3T3 cells.  In contrast, another preparation of brain FGF (Prep B) contains two mitogens, 
one (20-30%)  indistinguishable from the basic components in pituitary and brain (Prep A) FGF 
preparations  and  an  acidic activity (70-80%),  pl  5-6,  that migrates  more  slowly on acid gels, 
corresponding  to the acidic component  of brain  FGF described previously (Thomas,  K. A., M. 
C. Riley,  S. K. Lemmon,  N. C. Baglan, and  R. A. Bradshaw. 1980. J. Biol. Chem.  255:5517-5520.) 
In agreement with that report, none of the mitogens comigrates with fragments of myelin basic 
protein. Pituitary FGF was virtually inactive, brain (Prep A) FGF had a small  amount of activity, 
and  brain  (Prep  B)  FGF  was  highly  potent  (50% maximal  stimulation  at  15-30  ng/ml)  in 
stimulating the growth of human  umbilical  vein endothelial  (HUVE)  cells.  The acidic compo- 
nent of brain FGF, which is much more unstable at pH 8.5 than the basic one, can be protected 
by  reducing  agents,  whereas  the  basic  constituent  of  brain  FGF as well  as  pituitary  FGF  is 
unaffected  by  reducing  conditions.  Thus,  brain  FGF  preparations  may  contain  two  distinct 
mitogenic  activities, one  that  is acidic and  contains  HUVE cell  activity, and  a basic  mitogen 
that is similar to and  may be identical with pituitary FGF. 
In  1974, Gospodarowicz described the  presence of a  potent 
mitogen for mouse  3T3  fibroblasts in extracts of brain and 
pituitary (5). This activity was named fibroblast growth factor 
(FGF)  and  was  subsequently  purified  from  each  of these 
bovine tissues (6, 7). Both were characterized as basic molecules 
of-13,000 Mr that were acid and heat labile and as having 
common  biological activities for  a  variety of cultured  cells 
derived from embryonic mesoderm (9,  12). It was suggested 
that they might be either related or identical (12) until it was 
shown  that brain FGF could be separated into three forms, 
(FGF-1, 2, and 3) (7, 24),  corresponding to different peptide 
fragments of myelin basic protein (MBP), a structural protein 
of the  central  nervous  system.  Because  brain  and  pituitary 
FGF preparations had different amino acid compositions and 
antigenic properties (preparations of brain, but not pituitary, 
FGF caused autoimmune experimental encephalitis in guinea 
pigs presumably because of the presence of the MBP fragments 
(24)),  it was concluded that they were distinct entities. 
Subsequently  Thomas  et  al.  (22)  reported  that,  by  three 
different criteria, the  fragments of MBP did not possess the 
brain FGF activity. First, preparations of fragments produced 
from native bovine MBP, nearly identical to those reported to 
contain the brain FGF activity, were not mitogenic for BALB/ 
c 3T3 cells (22) or human dermal fibroblasts (1), Secondly, the 
mitogenic activity in brain FGF preparations could be sepa- 
rated  from  the  MBP  fragments  on  an  affinity  column  of 
insolubilized anti-MBP.  Finally, the  biological activity ap- 
peared to  be associated with  an acidic molecule, pI 5-6,  as 
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Since brain FGF was found not to be associated with the 
MBP  fragments,  it again  raised the  possibility that  the  two 
mitogens could be the same, i.e. pituitary FGF might also be 
acidic, contrary to its reported properties (6). In this report, we 
confirm the basic character of pituitary FGF. We also show 
that brain FGF contains at least two different mitogens, one 
acidic and one basic, the latter of which has properties similar 
to and hence may be identical with pituitary FGF. In agree- 
ment with our previous report (22),  neither the basic nor the 
acidic component of brain FGF corresponds to fragments of 
MBP. 
MATERIALS  AND  METHODS 
Anti-MBP Affinity Column 
A  chicken anti-bovine MBP affinity column was prepared and application 
and elution of samples were performed as described previously (22).  Briefly, 
bovine brain FGF samples were applied in phosphate buffered saline (PBS) (2) 
at room temperature to a  1.0-ml column and allowed to bind for about 10 rain. 
The column was washed with PBS until absorption at A280  and A~2o  was negligible 
and was then further washed with  1 M  NaCI in PBS and 2 M  guanidine-HCl. 
Aliquots from the three protein pools were taken for bioassay, diluted with 2.0 
mg/ml bovine serum albumin (BSA) (#4378, Sigma Chemical Co., St. Louis, 
MO)  in  PBS,  and dialyzed against PBS.  The  remainder of each sample was 
dialyzed with 1 mM acetic acid and lyophilized for application to gels. 
5DS and Acid Polyacrylamide 
Gel Electrophoresis 
15% SDS polyacrylamide gels were prepared and developed according to the 
method of Laemmli (14). Silver staining was performed as described previously 
(21).  Acid-gel-disc electrophoresis was  performed  by  the  type  'G'  modified 
Reisfeld method as described by Rodbard and Chrambach (20).  10%, 7.5 cm, 
polyacrylamide resolving gels and 3.0% stacking gels were polymerized with light 
in the presence of riboflavin-Y-phosphate.  Samples were dissolved in 10% glycerol 
and  a  1:10  dilution  of upper  running buffer.  Gels  were  electrophoresed  at 
approximately 4°C and 10 mamp for 2 h. This was the amount of time it took for 
a cytochrome c marker, which ran near the buffer front, to migrate close to the 
bottom of the gel. Sample lanes to be tested for bioactivity were cut into 0.25-cm 
segments and eluted by shaking overnight at 4°C in  1.0 ml of PBS and 2 mg/ml 
BSA. The remainder of the gel was stained with Coomassie Blue R 250. 
Isoelectric  Focusing in Polyacrylamide Slab Gels 
Isoelectric focusing slab gels, pH 3-10, 7.5% acrylamide, and 10-cm long were 
prepared as follows: 7.5 ml of 30% acrylamide:0.8%  bisacrylamide, 7.5 ml of 50% 
glycerol, 0.75 ml each of Pharmalytes pH 3-10 and pH 6.5-9 (Pharmacia Fine 
Chemicals, Uppsala, Sweden), and 12.5 ml H20 were combined and degassed. 
Polymerization  was  initiated  by  the  additions  of  1.0  ml  of  1%  ammonium 
persulfate and 7 ~1 of N,N,N',N'-tetramethylenediamine (TEMED).  Focusing 
was performed on an LKB 2117 multiphor electrofocusing  apparatus  with cooling 
at  4°C  and  cathode  and  anode electrodes  of  1  N  NaOH  and  I  N  H:~PO4, 
respectively. Small wells were punched in the gel ~ 1.5 cm from the anode and 
samples were loaded in  10-30 p.1 dHeO. Cytochrome c markers were applied at 
1.5 cm from both the cathode and anode. A  constant power of 15 watts was 
applied  until  the  voltage  reached  1000 (-30  rain),  after which the  run  was 
continued at a constant voltage of 1000 until the two cytochrome c markers met 
and the wattage and amperage had stabilized,  ~l~Z~-2 h  total electrofocusing 
time. Gel lanes to be tested for biological activity were cut into 0.5-em segments 
and eluted as described for acid gel samples. Gels were stained by the method of 
Reisner et al. (19). 
BALB/c 3T3 Cell Bioassay 
The assay of mitogenic activity for BALB/c 3T3 fibroblasts was performed by 
measuring incorporation of [methyl-:~H]-thymidine  into cells grown at 37°C in a 
humidified 5% CO~ atmosphere. Ceils were plated onto Costar 12 well-dishes (4 
cm  2) at 8,000 ceils/well in 1.0 ml of medium (designated DME) which consisted 
of Dulbecco's modified Eagle's medium (high glucose) (DM 326 with 3.7 g/l of 
sodium bicarbonate added, KC Biologicals, Inc., Lenexa, KS) containing 100 
units  penicillin.  0.1  mg of streptomycin  (Gibco  Laboratories,  Grand  Island 
Biological Co., Grand Island, NY), and 0. l  mg of glutamine (DME). This was 
supplemented with 10% calf serum (CS) (KC Biologicals, Inc.). -17 h  later, the 
ceils were washed two times with DME without serum and then  1.0 ml of the 
same medium containing 0.4% caIf serum was added to wells. Cells were allowed 
to become quiescent for 30-54 h, after which samples to be tested were introduced 
in an additional 100 ~tl or less of DME containing 2 mg/ml BSA along with 1.12 
ttg of dexamethasone in 20/tl of 50% ethanol. 16 h later, 2 gCi of [methyl-:~H] - 
thymidine (~70 Ci/mmoL ICN Pharmaceuticals, Inc., Irvine, CA) and 3/~g of 
unlabeled thymidine in 50 #l of DME were added. After a further 25 h, the assay 
was harvested. The ceils were washed three times with 1.0 ml 2.0 mg/ml BSA in 
HBSS and then precipitated with 1.0 ml of 5% TCA for 30 min on ice. After two 
more rinses with cold 5% TCA, precipitable material was solubilized with 1.0 ml 
of 2% Na~CO3 in 0.1  N  NaOH for 1 h. A sample of 0.5 mI of the incorporated 
label was neutralized with 70/~1 of 50% TCA and 10.0-ml scintillation cocktail 
(3a70, Research Products International Corp., Mt. Prospect, IL) was added for 
counting. Results were obtained  from triplicate  determinations and standard 
deviations were generally < 10% of reported values. 
Human Umbilical Vein Endothelial Cell Growth 
Assays 
Human umbilical vein endothelial (HUVE) cells were maintained as previ- 
ously described (16). For biological assay, cells between passage 3 and 11 were 
seeded into 35-mm culture dishes coated with 10 #g human fibroneetin/cm  2 at a 
density of 1 x  104 cells/dish in medium 199 and 20% fetal bovine serum (FBS) 
(Gibco  Laboratories).  Endothelial-cell  growth  factor (ECGF)  (an  extract as 
prepared in (15)) or FGF samples were added at this time, and cell cultures were 
fed every 2-3 d  with the appropriate supplements. The assay was terminated 
after  10 d.  The  ceils  were  harvested  by treatment  with 0.05%  trypsin-0.02% 
EDTA (Gibco Laboratories), trypsin was inactivated by the addition of soybean 
trypsin inhibitor (Sigma Chemical Co.) and duplicate hemocytometer counts 
obtained. Results are reported directly as the number of viable endothelial cells 
per dish. 
Preparation  of Pituitary FGF 
Bovine pituitary FGF was prepared by the method of Oospodarowicz (6, 7) 
with minor modifications. Frozen pituitaries (Pel-Freeze Biologicals, Rogers, AR, 
or, the generous gift of Dr. D. A. K. Roncari, University of Toronto, Toronto, 
Canada) were homogenized in 0.15 M  (NH4)2SO4 in the presence of 2.5 mg/1 
leupeptin, 2.5 mg/1 pepstatin (Sigma Chemical Co.), 0.25 mM  phenyl methyl 
sulfonyl fluoride (PMSF), and  1 mM EDTA. Acid extraction, subsequent am- 
monium sulfate precipitation, dialysis, and carboxymethyl-Sephadex  (CM-Seph- 
adex) 050 stepwise elutions were performed as previously described (6, 7) with 
the inclusion of 0.25 mM PMSF and 1 mM EDTA in all solutions. The Sephadex 
G-75 gel filtration column (2.5 x  90 cm), was run with 10-40 #m bed resin in 0.1 
M  ammonium bicarbonate. The active G-75 pool was loaded to the final CM- 
Sephadex C-50 column in 0.1  M  sodium phosphate, pH 6.0, containing 0.1  M 
NaCI. The column was washed extensively with 0.1  M  NaCI and 0.15 M  NaCI 
in the phosphate buffer, followed by a gradient from 0.15 to 0.6 M NaCI in the 
same buffer. The final active fractions were pooled, dialyzed versus H~O and 
stored lyophilized at -20°C for <6 mo. Final amounts of protein were estimated 
by amino acid analysis on a Durrum D-500 amino acid analyzer (Dionex Corp., 
Sunnyvale, CA). 
Preparations of Brain FGF 
FGF from bovine brain was isolated by the method of Gospodarowicz et al 
(7, 24) with the following modifications.In one purification from 11 kg of tissue 
(Prep  A), the active pool from the  CM-Sephadex C-50 column was dialyzed 
overnight against 0.1  M ammonium bicarbonate, pH 8.5, in tubing with a Mr = 
3,500 cutoff. This pool (1,400 ml) was then  concentrated at 4°C by pressure 
filtration over a 4-d period using a PM 10 membrane to 50 ml, followed by further 
concentration in a smaller diameter UM I 0 membrane to 30 ml. This step replaced 
the more rapid lyophilization normally used. This material was loaded directly 
onto the Sephadex G-75 column and the active fraction purified through the last 
CM-cellulose step. The pooled FGF fractions (Prep A) were stored in 30 mM 
ammonium formate, pH 6.0, at -20°C for 2-3 yr. 
In  a  second purification (Prep  B),  initial homogenization, extraction, and 
ammonium  sulfate  precipitation  of  16  kg  of brains  were  performed  in  the 
laboratory at room temperature, utilizing ice-cold buffers and refrigerated (4°C) 
centrifugation. All subsequent steps were done entirely in the cold. The following 
modifications were made to accelerate the first chromatography step. The active 
material from the second ammonium sulfate precipitation was dialyzed against 
water, Iyophilized, and dissolved in 500 ml of 0.1  M sodium phosphate, pH 6.0. 
This was mixed with 40 g of CM-Sephadex resin, equilibrated in the same buffer, 
stirred for 15 min, poured into a sintered glass filter and the excess liquid drawn 
out. The resin was mixed with starting buffer, poured into an 8.0-cm diameter 
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biological  activity  was eluted with 0.6 M NaC1 in the phosphate buffer,  dialyzed 
overnight  versus  distilled  water and lyophilized.  This  sample was dissolved  in 0.1 
M ammonium  bicarbonate,  pH 8.5 and applied and eluted from the Sephadex 
G-75 column as usual. The pooled active fractions from this chromatography 
were lyophilized  directly  and stored at -20°C for ~1.5 yr. 
Protein concentration  was estimated  on the basis  of an E2so  of 0.79 for a 1 mg/ 
ml solution  for(Prep A) and by weight for (Prep B). 
fl-A,  lercaptoethanol  Treatment of Brain and 
Pituitary FGF 
Pituitary (1/zg) and brain FGFs Prep A (5 #g) and Prep B (125 #g), in 0.08 M 
Tris-HCl, pH 8.5 were incubated  for 30 min at 37°C in the presence or absence 
of 0. I-0.2% ,8-mercaptoethanol.  The pituitary and brain  Prep A FGF samples 
were diluted to 0.5 ml with 2.0 mg/ml BSA in PBS and dialyzed  overnight  at 
4°C in tubing with a 3,500 mol wt cut off (18-mm diameter) against PBS before 
they were added to the 3T3-ceU bioassay.  The brain Prep B FGF samples were 
dialyzed against  several changes of distilled  H~O over an 8-10 h-period, lyophi- 
lized, resuspended in distilled H20, and aliquoted for bioassay and isoelectric 
focusing. 
RESULTS 
Isoelectric  Focusing of Brain and Pituitary FGF 
In initial studies to compare the properties of the two brain 
FGFs and pituitary FGF, appropriate preparations were ana- 
lyzed by isoelectric focusing. Pituitary (10 #g),  brain Prep A 
(25  #g),  and  Prep  B  (90  #g)  FGF  were  focused  in  7.5% 
polyacrylamide slab gels,  pH  range  3-10,  after  which  slices 
were cut, eluted, and tested for stimulation of incorporation of 
[methyl-:3H]-thymidine into BALB/c 3T3  cells.  Fig.  I  shows 
the activity profiles from these experiments. As seen, pituitary 
FGF (Fig. I A, closed circles) focused in the basic region of the 
Z 
C~I 
FIGURE  1  Isoelectric focusing 
profiles  of  FGF  activity.  The 
7.5% polyacrylamide gels with 
ampholytes of  pH  3-10  were 
focused  for  11/2-2  h  as  de- 
scribed in  the text. Gels were 
sliced  into  0.5-cm  slices  and 
eluted  in  1.0 ml  PBS, 2.0 rag/ 
ml  BSA  for  bioassay.  Results 
2  are  expressed  as  percent  of 
maximal  stimulation  for  each 
0  FGF, which was determined by 
analysis  of  the dose-response 
8 ~  curves of an aliquot from  the 
6 ,i  loaded  FGF-sample  tested  in 
the  BALB/c  3T3-cell  assay. 
4  Background  0.4% calf-serum 
2  (CS)  controls  were  not  sub- 
tracted to determine these val- 
ues,  Absolute  [3H]thymidine 
incorporated in cpm  at maxi- 
mal  stimulation  by  FGF  and 
10% CS controls are indicated 
below.  Arrows  align  the  re- 
gions of  the  acidic and  basic 
activities. (A) Pituitary FGF, 10 
/~g  protein  loaded, 0.5  p,I  as- 
sayed  from  eluted  slices  (Q); 
blank run without added pro- 
tO  8  6  4  2  0  tein, 5 p.l assayed (A); maximal 
cm  *  stimulation by FGF, 4257 +  58 
cpm; 10% CS, 4925 _  417 cpm.  (B) brain Prep A FGF, 25 #g loaded, 
5/d (O) assayed; maximal stimulation by FGF, 3948 4- 215 cpm; 10% 
CS, 5061 4- 393 cprn; (C)  brain Prep B FGF, 90 p.g loaded, 0.5/xl (O) 
or 5 #I  (0)  assayed; maximal stimulation by FGF, 4511 ±  518 cpm; 
10% CS as in A. 
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gel with a  pl  of 8-9,  confirming earlier reports of the  basic 
nature of this mitogenic activity (6).  Unexpectedly, the older 
preparation of brain FGF (Prep A) (Fig. 1 B) showed a similar 
broad activity-peak in this region of the focusing profile, with 
possibly a very small amount of activity (<5%) at a pl of ~6.0. 
This was in apparent contrast to our previous results in which 
we found all of the brain FGF activity was associated with an 
acidic molecule (22). However, when a second preparation of 
brain FGF (Prep B) was analyzed by isoelectric focusing (Fig. 
1 C), two active components were detected, a  basic mitogenic 
activity with a pI similar to that in brain Prep A and pituitary 
FGF, and a more prominent species that focused with a pI of 
about 6.0 in this system. Myelin basic protein fragments, which 
were  identified by staining of the gels,  appeared  to separate 
from the activities and migrated to the cathode, pI _>10.0. In 
control  experiments,  in which  blank lanes  with  no  applied 
protein were sliced, eluted, and tested in the 3T3-cell bioassay, 
no activity was seen (Fig. 1  A, open triangles). 
Anti-MBP Affinity Column Chromatography of 
Brain FGF 
In view of the fact that the Prep A of brain FGF contained 
primarily a  basic mitogenic activity, we reexamined this ma- 
terial after passage through an anti-MBP affinity column (22). 
300  /~g of brain Prep  A  FGF  were  loaded  in PBS  and  the 
column was washed sequentially with PBS,  1 M  NaCI, and 2 
M  guanidine-HCl. As reported previously (22),  almost all of 
the biological activity recovered, as determined in the BALB/ 
c 3T3 assay, was not retained by the column and came through 
in the breakthrough PBS pool (87%) even though this sample 
consisted largely of a  basic mitogen.  11% was  found  in the 
NaCI  pool  and  <2%  was  contained  in  the  guanidine-HC1 
fraction, which included the MBP fragments, the bulk of the 
protein loaded on the column (data not shown). 
The  introduction  of  the  highly  sensitive  silver-staining 
method for SDS polyacrylamide gels made it possible to iden- 
tify the components in all of the fractions eluted from the anti- 
MBP column (Fig.  2).  ~ 1-2 #g of protein, estimated by ab- 
sorption at A2~o, were analyzed from each fraction. As can be 
seen,  the  PBS  pool (lane  1)  contained three  major staining 
bands that did not comigrate with any of the MBP fragments 
eluted by 2 M guanidine-HC1 (lane 3). The material eluted by 
1 M NaCI (lane 2) contained some components found in both 
the guanidine-HC1 and PBS pools. Thus, the biological activity 
did not adhere to the anti-MBP affinity column and was not 
associated with  fragments of MBP,  confirming our previous 
report (22). 
Acid Gel Electrophoresis of Brain and 
Pituitary FGF 
Preparations  of pituitary,  brain  Prep  A  FGF,  containing 
primarily a  basic  mitogenic  component,  and  brain  Prep  B 
FGF, with two separable mitogenic activities, one acidic and 
one basic, were further examined by acid gel electrophoresis. 
10 #g of pituitary and  10-20 #g of brain Prep A  FGF were 
electrophoresed  on  10% potyacrylamide acid  pH  gels,  slices 
cut, and samples eluted for the 3T3-cell assay. As seen in Fig. 
3, pituitary (panel A) and brain Prep A  FGF (panel B) had a 
single mitogenic activity that migrated to the same apparent 
position in the gel, very close to the chicken egg-white lysozyme 
marker.  Although  the  brain  FGF  preparation  used  in  this 
experiment had been partially purified by passage through the 
anti-MBP affinity resin, unfractionated samples of brain Prep 
A FGF gave identical activity profiles in the acid gels. FIGURE  2  Silver-stained  pattern  o# 
SDS polyacrylamide (15%) gel electro- 
phoresis  of  fractions  eluted  from  the 
anti-MBP  Sepharose  chromatography. 
Gels were developed for approximately 
3 h at 20 mamp and processed for silver 
staining  as  described  previously  (21). 
Samples, 1-2/zg,  of each of the protein 
pools eluted from the anti-MBP Seph- 
arose chromatography of brain  Prep A 
FGF as described in  the text were ap- 
plied  to  lanes  1-3:  lane  1,  PBS pool; 
lane  2,  1  M  NaCI  pool;  lane  3,  2  M 
guanidine-HCI  pool.  Lane  4,  500  ng 
each  of  molecular  weight  markers: 
ovalbumin, 43,000 Mr [43]; chymotryp- 
sinogen, 25,000 Mr [25]; cytochrome c, 
12,500 Mr [12.5]. 
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FUGURE 3  Activity profiles 
of acid gel electrophoresis 
of FGF. Samples applied to 
10%  polyacrylamide  type 
'G' acid gels (19) were elec- 
trophoresed  as  described 
in the text. Gels were sliced 
into 0.25-cm  fragments and 
eluted  as  in  Fig.  1 for  the 
3T3-cell  bioassay.  Results 
are expressed  as described 
in  Fig.  1  with  each  FGF 
preparation examined in a 
separate experiment.  Elec- 
trophoresis of samples was 
from  right  to  left  and  mi- 
gration  was  analyzed rela- 
tive  to  the  cytochrome  c 
marker.  Arrows  indicate 
chymotrypsinogen  (chy), 
lysozyme  (/ys),  and  cyto- 
chrome  c  (cyt).  (A)  Pitui- 
tary FGF, 10/ag  loaded, 0.1 
#1 assayed; maximal stimu- 
lation by FGF, 31,600 _  701 
cpm; 10% CS, 26,219 + 2546 
cpm. (B) Brain  Prep A FGF, 
partially  purified  on  an 
anti-MBP  affinity  column, 
10-20  #g loaded, 1.0 #1  as- 
sayed; maximal stimulation 
by FGF, 5397 ___ 416 cpm; 10% CS, 8505 +  726 cpm. (C)  Brain-Prep B 
FGF, 90#g loaded, 1.0#1 (O) or 5btl (0) assayed; maximal stimulation 
by FGF, 8551 +  767 cpm; 10% CS 11,344 ___ 829 cpm. 
The  Coomassie  Blue  staining-patterns  from  the  acid  gel 
electrophoresis of pituitary  and this further purified brain Prep 
A  FGF  are  shown in Fig. 4.  As can be seen,  the brain FGF 
(lane  3)  still  contained  residual  MBP  fragments when it  was 
compared to the material eluted by 2 M guanidine-HCl  from 
the anti-MBP affinity column (lane 2). However, these peptides 
served as a visual marker, because the biological activity, which 
migrated  near lysozyme (lane  1, B),  and the MBP fragments, 
which migrated more slowly, were clearly separated in the acid 
gels.  Both the pituitary (lane  4)  and this  brain  FGF  sample 
had staining bands in the region of biological activity. 
In contrast,  when brain Prep  B  FGF  (90 #g) was analyzed 
by  acid  gel  eleetrophoresis,  two  separate  mitogenic  entities 
were seen (Fig. 3 C). There was a smaller peak of activity (20- 
30%) that migrated to the same position as pituitary  and brain 
Prep A FGF and a slower migrating component (70-80%)  that 
had  a  mobility  in  this  system  similar  to  chymotrypsinogen. 
This distribution of the two active components correlated well 
with  the  results  of  the  isoelectric  focusing  gels.  The  MBP 
fragments migrated approximately between the two peaks. 
In  addition,  it  was  found  that  virtually  100% recovery of 
activity of material loaded on the acid gels was obtained when 
slices  were  eluted  into  buffer  containing  carrier  BSA.  10  #1 
from samples eluted from sliced-blank  lanes  run without ap- 
plied protein showed no stimulation of [methyl-3H]-thymidine 
into 3T3 cells. 
Effects  of FGF on  HUVE cells 
FGF  preparations were tested for their ability to stimulate 
the  growth  of  HUVE  cells  (Fig.  5).  In  most  experiments, 
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tary-and brain-Prep A  FGF. Gels were devel- 
oped as in Fig. 3 and then stained with Coo- 
massie Blue R. Lane  I: chymotrypsinogen, 10 
#g, (A): lysozyme, q0/tg, (B): cytochrome c, 20 
/~g, (C).  Lane 2:2  M  guanidine-HCl fraction 
from  anti-MBP  affinity  chromatography,  20 
~g. Lane 3: brain-Prep A FGF, partially purified 
on the anti-MBP affinity column as in Fig. 3 B, 
10-20 ~g. Lane 4: pituitary FGF, 15 ~g. 
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Mitogenic effects of FGF on BALB/c 3T3-cells  and HUVE 
cells.  (A)  Stimulation of  [methyl-3H]-thymidine  into  BALB/c 3T3- 
cells by FGF. Results are expressed  as described in  Fig. I. Pituitary 
FGF (A); maximal stimulation by FGF, 3086 __. 456 cpm; 10% CS, 5084 
4- 417 cpm. Brain-Prep A FGF (O); maximal stimulation by FGF, 3201 
+  183  cpm;  10%  CS,  as  for  pituitary  FGF. Brain-Prep  B  FGF  (@); 
maximal stimulation by FGF, 8551 +  767 cpm; 10% CS, 10,724 -4- 308 
cpm.  (B)  Growth  of  HUVE  cells was  measured  after 10 d  and  is 
expressed as number of cells/35-mm dish, duplicate samples tested. 
20% fetal  bovine serum  served  as the  basal  control  and  maximal 
growth is that of cultures grown in the presence of 100/~g of ECGF. 
Amounts added to cell media, 2 ml/dish, are in  ng/ml. 
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pituitary FGF showed no activity, although occasionally, as 
shown in Fig. 5 B, a small amount was detectable when  100 
ng/ml or greater were  added.  By comparison, this  material 
showed half-maximal stimulation of activity in the  BALB/c 
3T3 cell assay at a dose of 0. !-0.5 ng/ml. Brain Prep A FGF, 
which produced a half-maximal response in the 3T3 cell bioas- 
say at 5-10 ng/ml, displayed activity in the HUVE cell assay, 
but even at 250 ng/ml, it had not reached 50% of the ECGF 
level.  In contrast, brain Prep B FGF was equipotent in both 
assays with half-maximal stimulation between 15 and 30 ng/ 
ml. In addition, it was as active in the HUVE cell assay at 4 
ng/ml as  brain Prep  A  FGF  was  at  250  ng/ml, a  60-fold 
difference. 
Stability Studies 
These brain and pituitary FGF preparations were also ana- 
lyzed for their stability when subjected to reducing conditions. 
Samples were  treated with or without /3-mercaptoethanol at 
37°C, pH 8.5, for 30 min and then dialyzed to remove reducing 
agents.  As shown in Table I, pituitary and brain Prep A FGF 
were not sensitive to these reducing conditions, as there was no 
significant difference in activities in the presence or absence of 
fl-mercaptoethanol when tested in the BALB/c 3T3 bioassay. 
In contrast, preparation B of brain FGF was markedly stabi- 
lized by fl-mercaptoethanol when subjected to  pH  8.5  and 
37°C and then dialyzed. In this experiment, there was a 40- 
50% reduction in biological activity in the absence of the thiol 
reagent, as compared with samples treated in its presence. 
This  stabilizing effect  of ~-mercaptoethanol was  further 
analyzed by isoelectric  focusing of brain Prep B FGF samples 
that  had  been incubated with  or without this  agent.  Fig. 6 TABLE  I 
~-Mercaptoethanol  Treatment of Bovine Brain and Pituitary 
FGF * 
-tiME  +tiME 
rig~ ml  cpm 
Pituitary FGF  0.5  5872 4- 329  5715 __. 90 
5  12590 ±  387  11771  ___ 545 
Brain Prep A  FGF  5  8413 _+ 190  7431 :I: 312 
50  11391  ±  704  13236 ±  514 
Brain  Prep B FGF  10  364 --_ 18  785 --- 72 
100  3261  +__ 125  5083 ±  355 
* Samples were treated with  or without/~-mercaptoethanol  (~ME), 
as described in the text, and tested in the 3T3-cell bioassay. Results 
are  expressed  as  cpm  ([3H]thymidine)  incorporated  into  TCA- 
precipitable  material.  Pituitary  FGF  and  brain  Prep A  were tested 
in the same experiment with 10% calf serum controls incorporating 
16,999 +  887 cpm;  maximal  stimulation  was 13,236 _  514 cpm.  In 
a separate experiment, brain Prep B FGF gave a maximal  stimula- 
tion of 5,083 +  355 cpm with  10% calf serum controls incorporating 
5640 +  375 cpm. 
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FIGURE  6  Isoelectric  fo- 
cusing of brain-Prep B FGF 
treated  with  or without  ,8- 
mercaptoethanol.  Brain- 
Prep  B  FGF,  125  #g,  was 
treated  with  or  without 
0.1-0.2%  /~-mercaptoetha- 
nol for 30 rain at 37°C, pH 
8.5. After extensive dialysis 
with distilled H20, samples 
were  lyophilized,  resus- 
pended  in  H20  and  fo- 
cused  in  7.5%  polyacryl- 
amide gels as described  in 
the text. Gel  slices, 0.5 cm, 
were eluted and 10 #1 from 
each was tested for biolog- 
ical  activity  in  the 3T3 cell 
assay. Results are expressed 
as  in  Fig.  1.  (A)  +  ,B-mer- 
captoethanol. (B) -/~-mer- 
captoethanol.  Maximal 
stimulation  by  FGF,  5,083 
4-  355  cpm;  10%  CS,  5,640 
4- 255 cpm. 
shows that  in  the absence of reductant  (panel B)  the acidic 
component of this brain FGF was nearly undetectable; how- 
ever, protection from inactivation was provided by the sulfhy- 
dryl compound (panel A), although there was still some de- 
crease in the acidic constituent. In contrast, there was no loss 
of activity of the basic component of brain Prep B FGF with 
or without reductant, revealing another similar property of this 
activity to  the  FGF of pituitary and  the  Prep  A  of brain. 
Samples prepared without growth factors but in the presence 
offl-mercaptoethanol were inactive when tested for biological 
activity. 
DISCUSSION 
The present studies have reexamined the relationship of brain 
and  pituitary  FGF.  Our  experiments  have  confirmed  that 
pituitary FGF is indeed basic as originally described (6). All of 
the biological activity focused in the basic region of the isoe- 
lectric focusing slab gels and experiments on focusing columns 
in sucrose density-gradients with cruder preparations of pitui- 
tary FGF also showed that the major mitogenic activity is basic 
(data not shown). 
When we compared pituitary FGF to two different prepa- 
rations of brain FGF by isoelectric focusing, we found that the 
brain samples gave markedly different activity-profiles. One 
preparation (Prep A) contained primarily a basic mitogen that 
was similar to pituitary FGF in that it migrated to the same 
position in the acid pH gels and was insensitive to sulfhydryl 
reagents at 37°C.  It was also shown not to be related to the 
MBP fragments. This was established in both electrophoresis 
systems utilized in these studies and by the alTmity chromatog- 
raphy and its subsequent analysis in SDS gels. Other investi- 
gators are in agreement with this finding (1,  13). 
The  unexpected result  was  that  this preparation of brain 
FGF contained little of the factor with the acidic pl that we 
originally described  (22).  However,  analyses,  by  the  same 
methods, of a  second preparation (Prep B),  clarified this ap- 
parent discrepancy. We found this sample contained both an 
acidic component with mitogenic activity, corresponding to the 
activity described in our earlier report (22),  and a  basic con- 
stituent resembling pituitary and brain Prep A FGF. 
Although both the acidic and basic components were stim- 
ulatory for  BALB/c 3T3  fibroblasts, only preparations  that 
contained the acidic factor showed significant activity in the 
HUVE-cell assay. The amount of activity for HUVE ceils was 
reflected in the quantity of the acidic component in a  given 
sample; that is, pituitary FGF had virtually no activity, brain 
Prep A  FGF had very small amounts  of activity, and  brain 
Prep B FGF 'was a  highly potent mitogen for these cells. In 
addition, only in the case of brain Prep B FGF was the growth- 
factor preparation as active in the HUVE-cell assay as it was 
in  the  3T3-cell  assay.  That  the  acidic  factor  contains  the 
HUVE-cell activity, though, is only inferred as we have been 
unable to test samples derived from polyacrylamide gels di- 
rectly in  these  cultures  without  unacceptable  losses  in  cell 
survival. 
It is possible that the two components in preparation B of 
brain FGF are related in some way. For example, one activity 
could  be  produced  from  the  other  constituent  by  a  latent 
proteolytic event. However, the fact that only brain FGF with 
the acidic material is active for HUVE cells, which is stabilized 
by fl-mercaptoethanol, whereas  the  basic components  from 
brain and pituitary FGF do not show these properties, suggests 
that the two mitogenic activities are distinguishable entities. 
The fact that the acidic and basic mitogens are apparently 
distinct proteins suggests that  the variable amounts of these 
constituents in different brain FGF preparations are probably 
due  to other  reasons.  There  were  several differences in  the 
purification and storage of the two brain FGF samples used in 
these studies. The most significant was that Prep B was only 
purified through the Sephadex G-75 column, whereas Prep A 
was purified through the final CM-52 ion exchange column. 
However, this cannot account  for the virtual absence of the 
acidic component in the further purified brain FGF. First, all 
of the  studies presented in  our earlier paper (22)  were  per- 
formed with brain FGF purified on a column of CM-52 with 
gradient elution and only the acidic component was observed 
on  isoelectric focusing.  Second,  both  the  acidic  and  basic 
mitogenic components were observed with isoelectric focusing 
and  acid gel electrophoresis when  brain  Prep  B  FGF  was 
further  purified  through  a  final  CM-52  column  (data  not 
shown).  However, it should be noted that the bound protein 
fraction was eluted in a single step because biological activity 
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purifications of brain FGF. In these experiments, the acid gel 
electrophoresis showed identical amounts of the two activities, 
20-30% basic and 70-80% acidic, as had been seen with the G- 
75 purified material. 
Aging of brain FGF preparations may account, in part, for 
the loss of one constituent relative to the other. We have noted 
that brain FGF is generally less stable than pituitary FGF and 
this could be due  to  the  presence of the  more  labile acidic 
component in brain FGF preparations. However, the differ- 
ence in age in the brain-FGF samples used in these studies is 
not so great as to suggest that this is the main factor in the 
differences in content of the acidic mitogen. Rather, it is more 
likely that during manipulation of the samples or at other steps 
in the purification of brain FGF, recoveries of the two mitogens 
are  altered.  Slight  variations  in  pH  and  ionic  strength  of 
buffers, temperature, length of dialysis or concentration, pool- 
ing of column fractions, storage conditions, and the age of the 
animals from  which  the  bovine brains were  obtained could 
determine the final ratio of the acidic to basic components. For 
example, it is possible that the loss of the acidic constituent in 
Prep A  brain-FGF could be accounted for by the prolonged 
concentration  step  at  pH  8.5  prior  to  the  Sephadex  G-75 
purification, since it has been shown that the acidic component 
is labile to treatment at this pH at 37°C. Alternatively, storage 
of samples in solution (Prep A) versus lyophilized (Prep  B) 
could be a  contributing factor. At the present time, it is not 
clear what factors lead to the variable amounts of the acidic 
and basic constituents of brain FGF. 
We are not certain why we did not observe the basic com- 
ponent of brain FGF in our earlier studies (22). This form was 
probably contained in the brain FGF we originally analyzed, 
but  because of insensitivity of the  biological assay and  the 
isoelectric focusing methods utilized at that time, which was 
20-fold less sensitive, it was not detected. However, we do not 
feel that loss of the basic constituent in the earlier experiments 
was due to dialysis of samples with 10 mM acetic acid, as has 
been suggested by Gospodarowicz and  Mescher (I0).  In the 
initial reports of the characterization of brain FGF, substantial 
biological activity  (80%)  was  retained  when  samples  were 
treated for 24 h with as great as 100 mM acetic acid (7). 
In view of the conflicting results that  have been obtained 
from isoelectric focusing of brain-FGF preparations, this may 
not be an adequate method with which solely to analyze these 
growth factors, especially when identification depends upon a 
mitogenic bioassay. In particular, there are difficulties in inter- 
preting the basic region of isoelectric focusing-profiles. It has 
been noted that basic ampholytes can stimulate fibroblasts to 
divide (4). Also, alkaline pH can result in mitosis of 3T3 cells 
(25).  Although assaying a blank run without added protein is 
a  useful control, there exists the possibility that some of the 
mitogenic activity in a  test sample is due to ampholytes that 
may act differently when associated with proteins. In addition, 
we cannot eliminate the possibility that some artifactual mito- 
genic  activity  in  focusing  experiments  was  observed  when 
larger  sample  volumes,  5-10  /zl, were  assayed,  as  we  have 
sometimes seen  >100%  recovery, and  the  ratio of acidic to 
basic material in brain (Prep B) FGF did not always correlate 
with the analysis of the same preparation in acid gels. There- 
fore, this latter method that  does not have unusual  buffers, 
appears to give a  more reliable indication of the amounts of 
the two constituents found in brain FGF preparations. 
The  presence  of two  distinct mitogens in  preparations of 
brain FGF  may explain the  conflicting results with  human 
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endothelial-cell growth in culture. While Gospodarowicz and 
colleagues (8) have shown that  high concentrations of brain 
and pituitary FGF can promote the growth of normal human- 
endothelial cells, these results have been difficult to confirm 
independently (15, 16). It is also possible that bovine pituitaries 
contain the acidic growth activity. In our studies on pituitary 
FGF, we have noted the presence of other components mito- 
genic for  3T3  ceils, especially as  seen  by gel filtration, and 
Maciag et al. (15) have shown that pituitary extracts contain 
significant levels of activity for HUVE cells. Because we have 
only studied normal human endothelial-ceU growth with these 
reagents, it is presently not possible to extend our findings to 
normal bovine-endothelial  cells (1 l, 18, 23). However, it should 
be noted that  pituitary FGF, prepared in our laboratory, is 
highly active for an established line of bovine vascular-endo- 
thelial cells (P.  R. Kelley, Collaborative Research Inc., Wal- 
tham, MA, personal communication), an observation consistent 
with other laboratories (3,  11). 
In conclusion, we feel that the experiments presented here 
have helped to clarify the contradictory findings surrounding 
studies with bovine fibroblast growth factors. We have defini- 
tively shown  that brain FGF activity is not  associated with 
fragments of MBP,  but that these preparations do contain a 
basic component with properties very similar to pituitary FGF. 
At present, they are indistinguishable. The acidic constituent 
of brain FGF, present in some preparations, resembles closely 
and may be related to endothelial-cell growth factor, pI 5.0- 
6.0,  that has been characterized by Maciag et al. (15,  t7).  If 
these biological assignments prove to be correct, it would be 
reasonable to refer to the basic mitogens of brain and pituitary 
as  "fibroblast  growth  factor"  and  retain  the  designation 
"endothelial-cell growth factor" for the acidic component. 
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